AzTrials
AzTrials

Gag ReflexNCT07509918

Mucoadhesive Gels in Controlling Gag Reflex Among Children During Dental Radiographic Examination

A study testing Tannic Acid Mucoadhesive Gel (Topical), Zinc Acetate Mucoadhesive Gel (Topical) and Lidocaine Gel (Topical) in people with Gag Reflex and Child, run by Cairo University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized clinical trial compares tannic acid-zinc acetate mucoadhesive gel with lidocaine gel for reducing gag reflex in children aged 8-10 years during radiographic dental examination Gag reflex severity and pulse rate will be assessed before and after gel application. Read more about this study

Who is it for?
Ages 8 to 10 yearsHealthy volunteers can take part
Conditions the study is for
Gag Reflex, Child
What is being tested?
Tannic Acid Mucoadhesive Gel (Topical), Zinc Acetate Mucoadhesive Gel (Topical) and Lidocaine Gel (Topical)
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteEgypt
Study dates
1 Sep 2026to 1 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • The study will include children aged between 8 and 10 years .
  • Pediatric dental patients requiring intraoral radiographs for diagnostic or treatment purposes will be recruited.
  • Children present with a fully erupted maxillary last molar to allow standardized placement of the radiographic film for gag reflex stimulation.
  • Written informed consent will be obtained from parents or legal guardians before participation.

Who cannot join

  • Children with systemic diseases or neurological disorders that may influence gag reflex,such as epilepsy or cerebral palsy.
  • Those with a history of allergies to the materials that will be used in the study gels are not considered eligible.
  • Patients with acute respiratory infections, oropharyngeal inflammation, or enlarged tonsils at the time of the examination are excluded to avoid confounding variables.
  • Children taking medications known to modify gag reflex or pulse rate, such as sedatives or antihistamines, are not included.
  • Uncooperative or extremely anxious children, classified as Frankl ratings 1 or 2, are excluded

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sara Usama Elkholy, Dental degree contact

01019603286

Sara.osama@dentistry.cu.edu.eg

Mohamed Atef Abdelhakim, Dental contact

01154059058

vertigo15.ma@gmail.com

Egypt1 site
  • Faculty of dentistry Cairo university

    Cairo

    Faculty Of Cairo university, 01002159535, info@dentistry.cu.edu.eg

    Mahmoud Hamdy Eid, Professor

Other trials in Egypt

About this study

Official title: Clinical Efficacy of Three Mucoadhesive Gels in Controlling Gag Reflex Among Children Aged 8-10 Years During Radiographic Examination:A Randomized Pilot Clinical Trial

This randomized clinical trial compares tannic acid-zinc acetate mucoadhesive gel with lidocaine gel for reducing gag reflex in children aged 8-10 years during radiographic dental examination Gag reflex severity and pulse rate will be assessed before and after gel application. The study evaluates the effectiveness of the tested gel as a potential alternative to lidocaine.

Read the detailed description

This randomized controlled clinical trial evaluates the effectiveness of a tannic acid-zinc acetate mucoadhesive gel compared to lidocaine gel in reducing gag reflex in children aged 8-10 years during dental procedures. Participants will be randomly assigned to receive either gel applied to the posterior palate before a standardized gag-inducing procedure. The primary outcome is the reduction in gag reflex severity using a validated scoring index. The secondary outcome is the change in pulse rate measured at baseline, after application, and during the procedure. This study aims to assess whether the tested mucoadhesive gel can provide an effective alternative to lidocaine with improved patient comfort.

Conditions
Gag Reflex, Child
Being tested
Tannic Acid Mucoadhesive Gel (Topical), Zinc Acetate Mucoadhesive Gel (Topical), Lidocaine Gel (Topical)
Keywords
Gag reflex, Radiographic dental examination, Pediatric dentistry, Mucoadhesive gels
Medical subject headings
Gagging

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tannic Acid Mucoadhesive Gel (Topical)Drug

    A mucoadhesive gel containing tannic acid at a specified concentration is applied topically to the oral mucosa prior to the dental procedure. The gel is intended to reduce gag reflex through its astringent and protein-precipitating properties.

  • Zinc Acetate Mucoadhesive Gel (Topical)Drug

    A mucoadhesive gel containing zinc acetate at a specified concentration is applied topically to the oral mucosa before the dental procedure. The formulation is used to evaluate its potential effect in reducing gag reflex.

  • Lidocaine Gel (Topical)Drug

    A topical lidocaine gel at an appropriate concentration is applied to the oral mucosa prior to the dental procedure as a standard local anesthetic agent for gag reflex suppression.

Study groups in NCT07509918
Study groupRoleWhat they receive
Participants receive topical tannic acid mucoadhesive gel.Experimentaltannic acid mucoadhesive gel applied intraorally prior to the dental procedure to evaluate its effectiveness in reducing gag reflex
Receives: Drug: Tannic Acid Mucoadhesive Gel (Topical)
Participants receive topical zinc acetate mucoadhesive gelExperimentalzinc acetate mucoadhesive gel applied intraorally prior to the dental procedure to assess its effect on gag reflex reduction.
Receives: Drug: Zinc Acetate Mucoadhesive Gel (Topical)
Participants receive topical lidocaine gelActive comparatorlidocaine gel applied intraorally prior to the dental procedure as a standard treatment comparator for gag reflex control
Receives: Drug: Lidocaine Gel (Topical)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gag reflex severity score using a 5-point Likert faces scale

    Gag reflex severity is assessed using a 5-point Likert faces scale (score range: 0-5), where higher scores indicate greater gag reflex severity, following application of the assigned topical gel during the dental procedure.

    Measured: Immediately after gel application during the dental procedure (single visit)

Secondary outcomes (1)
  1. Pulse rate (beats per minute)

    Pulse rate is measured using a pulse oximeter and recorded in beats per minute (bpm) to assess physiological response during the dental procedure following application of the assigned topical gel.

    Measured: During the dental procedure (single visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion1 Oct 2026 (estimated)
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07509918
Sponsor's protocol ID
Gag reflex in children
Status last verified
Mar 2026
First submitted
28 Mar 2026
Last updated
8 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared to protect participant confidentiality and due to institutional policies.

Publications

  • Elbay M, Tak O, Sermet Elbay U, Kaya C, Eryilmaz K. The use of low-level laser therapy for controlling the gag reflex in children during intraoral radiography. Lasers Med Sci. 2016 Feb;31(2):355-61. doi: 10.1007/s10103-016-1869-z. Epub 2016 Jan 11.

    PubMed 26754182
  • Nikkerdar N, Seyedi H, Mirzaeei S, Safari-Faramani R, Golshah A. Comparative effects of three mucoadhesive gels containing lidocaine, zinc acetate, and tannic acid on the gag reflex of dental patients: a randomized double-blind clinical trial. BMC Oral Health. 2024 Nov 27;24(1):1442. doi: 10.1186/s12903-024-05248-9.

    PubMed 39604959
  • Eachempati P, Kumbargere Nagraj S, Kiran Kumar Krishanappa S, George RP, Soe HHK, Karanth L. Management of gag reflex for patients undergoing dental treatment. Cochrane Database Syst Rev. 2019 Nov 13;2019(11):CD011116. doi: 10.1002/14651858.CD011116.pub3.

    PubMed 31721146
  • Bassi GS, Humphris GM, Longman LP. The etiology and management of gagging: a review of the literature. J Prosthet Dent. 2004 May;91(5):459-67. doi: 10.1016/S0022391304000939.

    PubMed 15153854

Questions about this trial

What is this clinical trial studying?

A study testing Tannic Acid Mucoadhesive Gel (Topical), Zinc Acetate Mucoadhesive Gel (Topical) and Lidocaine Gel (Topical) in people with Gag Reflex and Child, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sara Usama Elkholy, Dental degree (01019603286, Sara.osama@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gag reflex severity score using a 5-point Likert faces scale (time frame: Immediately after gel application during the dental procedure (single visit)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07509918, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in